Prevalence rates of psychotropic medications for students placed in residential facilities

Behavioral Disorders

Volumn 33, Issue 2, 2008, Pages 99-107

  Ryan, Joseph B ^a   Reid, Robert ^b   Gallagher, Ken ^b   Ellis, Cynthia ^c  

^a CLEMSON UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52649121323     PISSN: 01987429     EISSN: None     Source Type: Journal    
DOI: 10.1177/019874290803300204     Document Type: Article

References (34)

1. Connor, D. F., Boone, R. T., Steingard, R.J., Lopez, I. D., & Melloni, R. H. (2003). Psychopharmacology and aggression: II. A meta-analysis of nonstimulant medication effects on overt aggression-related behaviors in youth with SED. Journal of Emotional and Behavioral Disorders, 11, 157-168.
2. Connor, D. F., Ozbayrak, K. R., Harrison, R. J., & Melloni, R. H. (1998). Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. Journal of Child and Adolescent Psychopharmacology, 8, 27-38.
3. Cullinan, D., Gadow, K. D., & Epstein, M. H. (1987). Psychotropic drug treatment among learning disabled, educable mentally retarded, and seriously emotionally disturbed students. Journal of Abnormal Child Psychology, 15, 469-477.
4. Dulcan, M. K. (2007). Helping parents, youth, and teachers understand medications for behavioral and emotional problems. Washington, D. C: American Psychiatric Press.
5. Epstein, M. H., Singh, N. N., Luebke, J., & Stout, C. E. (1991). Psychopharmacological intervention. II: Teacher perceptions of psychotropic medication for students with learning disabilities. Journal of Learning Disabilities, 24, 477-483.
6. Falk, K. B., & Wehby, J. H. (2001). The effects of peer-assisted learning strategies on the beginning reading skills of young children with emotional or behavioral disorders, Behavioral Disorders, 26, 344-359.
7. Fishbein, W. (1997). But is it ethical to withhold treatment to which some children respond? Brown University Child & Adolescent Behavior Letter, 13, 1-3.
8. Forness, S. R., Kavale, K. A., Sweeney, D. P., & Crenshaw, T. M. (1999). The future of research and practice in behavioral disorders: psychopharmacology and its school implications. Behavioral Disorders, 24, 305-317.
9. Gadow, K. D. (1997). An overview of three decades of research in pediatric psychopharmacoepidemiology. Journal of Child and Adolescent Psychopharmacology, 7, 219-236.
10. Greenbaum, P. E., & Dedrick, R. F. (1996). National adolescent and child treatment study (NACTS): Outcomes for children with serious emotional and behavioral disturbance. Journal of Emotional and Behavioral Disorders, 4, 130-146.
11. Hahn, B. A. (1995). Children's health: Racial and ethnic differences in the use of prescription medications. Pediatrics, 101, 727-732.
12. Halfors, D., & Fallon, T. (1998). An examination of psychotropic drug treatment for children with serious emotional disturbance. Journal of Emotional and Behavioral Disorders, 6, 56-66.
13. Jensen, P. S., Kettle, L., Roper, M. T., Sloan, M. T., Dulcan, M. K., & Hoven, C., et al. (1999). Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 797-804.
14. Lin, K. L., & Poland, R. E. (1995). Ethnicity, culture, and psychopharmacology. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 1907-1917). New York: Raven Press.
15. Mattison, R. E. (1999). Use of psychotropic medications in special education students with serious emotional disturbance. Journal of Child and Adolescent Psychopharmacology, 9, 149-155.
16. Mental Health Sanctuary. (2008). Psychotropic medications, Retrieved July 6, 2008, from http:// www.mhsanctuary.com/rx/medications.htm
17. MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
18. National Institute of Mental Health. (2003). Attention deficit disorder withhyperactivity. Retrieved December 10, 2006, from http://www.nimh. nih.gov
19. Oswald, D. P. (2002). The new medical model and beyond: A response to Forness and Kavale. Behavioral Disorders, 27, 155-157.
20. Pappadopulos, E., Maclntyre, J. C., Crimson, M. L., Findling, R. L., Malone, R. P., & Derivan, A., et al. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 145-161.
21. Runnheim, V. A., Frankenberger, W. R., & Hazelkorn, M. N. (1996). Medicating students with emotional and behavioral disorders and ADHD: A state survey. Behavioral Disorders, 21, 306-314.
22. Ryan, J. B., Reid, R., & Ellis, C. (In press). A survey of special educator knowledge regarding psychotropic interventions for students with emotional and behavioral disorders. Remedial & Special Education.
23. Safer, D. J., & Malever, M. (2000). Stimulant treatment in Maryland public schools. Pediatrics, 106, 533-539.
24. Safer, D. J., & Zito, J. M. (2000). Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of attention deficit hyperactivity disorder. In L. Greenhill & B. Osmon (Eds.), Ritalin: Theory and practice, (2nd ed., pp. 7-26) Larchmont, NY: Liebert.
25. Schur, S. B., Sikich, L., Findling, R. L., Malone, R. P., Crimson, M. L., & Derivan, A., et al. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: A review. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 132-143.
26. Stanford Research Institute. (2008). Special education elementary longitudinal (SEEL) study of elementary and middle school students receiving special education. Retrieved July 6, 2008, from www.seels.net/search/tables/1/ si1b8b1frm. html
27. Sussman, L. K., Robins, L. N., & Earls, F. (1987). Treatment-seeking for depression by black and white Americans. Social Science Medicine, 24, 187-196.
28. Sweeney, D. P., Forness, S. R., & Levitt, J. G. (1998). An overview of medications commonly used to treat behavioral disorders associated with autism, Tourette syndrome, and pervasive developmental disorders. Focus on Autism and Other Developmental Disabilities, 13, 144-150.
29. Thomas, C. P., Conrad, P., Rosemary, C., & Goodman, E. (2006). Trends in the Use of Psychotropic Medications Among Adolescents, 1994 to 2001. Psychiatric Services, 57, 63-69.
30. Thompson PDR (2003). Monthly Prescribing Reference, 19, 106.
31. U.S. Department of Education. (2004). Twenty-sixth annual report to Congress on the implementation of the Individuals With Disabilities Education Act. Washington, DC: Author.
32. Werry, J. S. (1993). Introduction: A guide for practitioners, professionals, and public. In J. S. Werry, & M. G. Aman (Eds.), Practitioner's guide to psychoactive drugs for children and adolescents (pp. 3-21). New York: Plenum.
33. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025-1030.
34. Zito, J. M., Safer, D. J., dosReis, S., Madger, L. S., & Riddle, M. A. (1997). Methylphenidate patterns among Medicaid youth. Psychopharmacology Bulletin, 33, 143-147.